AMJ

10/28/2026

Healthcare worker burnout may vary significantly across career stages.

A cross-sectional study found burnout in 66.91% of hospital professionals, with the highest prevalence among those with 16–20 years of service.

The findings highlight the potential need for career-specific workforce support.

Read more: https://hubs.la/Q04CC36n0

10/26/2026

Starting HPV vaccination at ages 9–10 was linked to higher vaccine completion rates by age 13.

New findings presented at IDWeek 2026 showed that 61.6% of children who started earlier completed the series, compared with 45.1% of those starting at ages 11–12.

Read more:

Household contacts drive infant hepatitis B risk, challenging selective guidance. Read more on why Hepatitis B Vaccination remains vital.

10/26/2026

Grape skin extract shows a potential signal for dry eye - but it’s far from proven.

Gains appeared on tear production and fatigue, yet validated indices like the OSDI showed no significant difference.

Full story on AMJ: https://hubs.ly/Q04C33MG0

10/25/2026

Could immersive VR aid recovery after acute respiratory distress syndrome?

Patients using it showed greater cognitive and quality-of-life gains - but they also received more structured rehab, muddying the picture.

Learn more: https://hubs.ly/Q04C33lx0

10/24/2026

More young adults are surviving stroke - but also living longer with its consequences.

As incidence climbs and acute survival improves, a growing population faces long-term disability and recurrence risk.

Explore the findings: https://hubs.ly/Q04C32-H0

10/23/2026

What is the true economic cost of antimicrobial resistance?

At the ID WEEK 2026 congress, researchers analyzed data across 21 regions, 12 infectious syndromes, and 22 bacterial pathogens, revealing which infections and pathogens are driving trillions in global losses and where the burden falls hardest.

Read more: https://hubs.la/Q04C8TDj0

Antimicrobial resistance was associated with $3.5 trillion in global economic losses in 2021. Read more about the clinical burden.

10/22/2026

How much cancer is preventable? A global analysis points to infections behind 12% of all cases.

Much of that burden - from HPV to hepatitis B - is addressable through vaccination, screening and antiviral therapy.

Explore the findings: https://hubs.la/Q04C31y40

10/22/2026

Could long-acting injectable HIV treatment hold up outside clinical trials?

At the IDWeek 2026 congress, researchers analyzed five years of real-world data from 7,995 people with HIV who switched to injectable cabotegravir plus rilpivirine, and the results reveal how many maintained viral suppression and why some discontinued.

Read more: https://hubs.la/Q04C2dby0

Long-acting HIV treatment maintained viral suppression in 94% of patients, with just 1% experiencing virologic failure. Read more.

10/20/2026

In infectious diseases, the next challenge is never far away. Neither is the science to tackle it.

At , new evidence on emerging pathogens, HIV, vaccines, and infection prevention will take center stage.

Join AMJ Microbiology & Infectious Diseases for the research and clinical insights that matter: https://hubs.la/Q04z_J0y0

10/19/2026

Could your deodorant be triggering your skin reaction?

An analysis found allergens in almost every popular product - but “fragrance free” labels meant fewer of them.

Explore the findings: https://hubs.la/Q04Bqm920